Updated Date:
14 Nov 2025
Product Detail:
XELJANZ tofacitinib (as citrate) 1mg/mL oral solution bottle
Shortage Status:
Anticipated
AUST R:
386772
Availability:
Available
Active Ingredient:
tofacitinib citrate
Reason:
Manufacturing
Dosage Form:
Solution
Supply Impact Dates
From 31 Dec 2025
To 15 Feb 2026
Management Action:
Sponsor is closely controlling the supply. Other dosage forms are available and patients and carers are advised to consult their healthcare professional to discuss alternative treatment options.
